Pathogenic variants in


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
02 03 2022
Historique:
entrez: 2 3 2022
pubmed: 3 3 2022
medline: 27 4 2022
Statut: ppublish

Résumé

Central conducting lymphatic anomaly (CCLA), characterized by the dysfunction of core collecting lymphatic vessels including the thoracic duct and cisterna chyli, and presenting as chylothorax, pleural effusions, chylous ascites, and lymphedema, is a severe disorder often resulting in fetal or perinatal demise. Although pathogenic variants in RAS/mitogen activated protein kinase (MAPK) signaling pathway components have been documented in some patients with CCLA, the genetic etiology of the disorder remains uncharacterized in most cases. Here, we identified biallelic pathogenic variants in

Identifiants

pubmed: 35235341
doi: 10.1126/scitranslmed.abm4869
doi:

Substances chimiques

MDFIC protein, human 0
Myogenic Regulatory Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabm4869

Auteurs

Alicia B Byrne (AB)

Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.
Clinical and Health Sciences, University of South Australia, 5001 Adelaide, Australia.

Pascal Brouillard (P)

Human Molecular Genetics, de Duve Institute, University of Louvain, 1200 Brussels, Belgium.

Drew L Sutton (DL)

Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.

Jan Kazenwadel (J)

Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.

Saba Montazaribarforoushi (S)

Adelaide Medical School, University of Adelaide, 5005 Adelaide, Australia.

Genevieve A Secker (GA)

Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.

Anna Oszmiana (A)

Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.

Milena Babic (M)

Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.
Department of Genetics and Molecular Pathology, SA Pathology, 5000 Adelaide, Australia.

Kelly L Betterman (KL)

Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.

Peter J Brautigan (PJ)

Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.
Department of Genetics and Molecular Pathology, SA Pathology, 5000 Adelaide, Australia.

Melissa White (M)

Adelaide Medical School, University of Adelaide, 5005 Adelaide, Australia.
Genome Editing Program, South Australian Health and Medical Research Institute, 5000 Adelaide, Australia.
South Australian Genome Editing Facility, University of Adelaide, 5005 Adelaide, Australia.

Sandra G Piltz (SG)

Adelaide Medical School, University of Adelaide, 5005 Adelaide, Australia.
Genome Editing Program, South Australian Health and Medical Research Institute, 5000 Adelaide, Australia.
South Australian Genome Editing Facility, University of Adelaide, 5005 Adelaide, Australia.

Paul Q Thomas (PQ)

Adelaide Medical School, University of Adelaide, 5005 Adelaide, Australia.
Genome Editing Program, South Australian Health and Medical Research Institute, 5000 Adelaide, Australia.
South Australian Genome Editing Facility, University of Adelaide, 5005 Adelaide, Australia.

Christopher N Hahn (CN)

Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.
Adelaide Medical School, University of Adelaide, 5005 Adelaide, Australia.
Department of Genetics and Molecular Pathology, SA Pathology, 5000 Adelaide, Australia.
ACRF Cancer Genomics Facility, Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.

Matthias Rath (M)

Department of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, 17489 Greifswald, Germany.

Ute Felbor (U)

Department of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, 17489 Greifswald, Germany.

G Christoph Korenke (GC)

Department of Neuropediatrics, University Children's Hospital, Klinikum Oldenburg, 26133 Oldenburg, Germany.

Christopher L Smith (CL)

Jill and Mark Fishman Center for Lymphatic Disorders, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Division of Cardiology, Children's Hospital of Philadelphia and Department of Pediatrics Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA 19104, USA.

Kathleen H Wood (KH)

Division of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Sarah E Sheppard (SE)

Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Denise M Adams (DM)

Vascular Anomalies Centre, Division of Haematology/Oncology, Cancer and Blood Disorders Centre, Boston Children's Hospital, Boston, PA 02115, USA.

Ariana Kariminejad (A)

Kariminejad-Najmabadi Pathology and Genetics Centre, Tehran, Iran.

Raphael Helaers (R)

Human Molecular Genetics, de Duve Institute, University of Louvain, 1200 Brussels, Belgium.

Laurence M Boon (LM)

Human Molecular Genetics, de Duve Institute, University of Louvain, 1200 Brussels, Belgium.
Center for Vascular Anomalies, Division of Plastic Surgery, VASCERN VASCA European Reference Centre, Cliniques Universitaires Saint-Luc and University of Louvain, 1200 Brussels, Belgium.

Nicole Revencu (N)

Center for Vascular Anomalies, Division of Plastic Surgery, VASCERN VASCA European Reference Centre, Cliniques Universitaires Saint-Luc and University of Louvain, 1200 Brussels, Belgium.
Centre for Human Genetics, Cliniques Universitaires Saint-Luc and University of Louvain, 1200 Brussels, Belgium.

Lynette Moore (L)

Adelaide Medical School, University of Adelaide, 5005 Adelaide, Australia.
Anatomical Pathology, SA Pathology, 5000 Adelaide, Australia.

Christopher Barnett (C)

Paediatric and Reproductive Genetics Unit, South Australian Clinical Genetics Service, Women's and Children's Hospital, 5006 Adelaide, South Australia, Australia.

Eric Haan (E)

Adelaide Medical School, University of Adelaide, 5005 Adelaide, Australia.

Peer Arts (P)

Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.

Miikka Vikkula (M)

Human Molecular Genetics, de Duve Institute, University of Louvain, 1200 Brussels, Belgium.
Center for Vascular Anomalies, Division of Plastic Surgery, VASCERN VASCA European Reference Centre, Cliniques Universitaires Saint-Luc and University of Louvain, 1200 Brussels, Belgium.
Centre for Human Genetics, Cliniques Universitaires Saint-Luc and University of Louvain, 1200 Brussels, Belgium.
Walloon Excellence in Life Sciences and Biotechnology, University of Louvain, 1200 Brussels, Belgium.

Hamish S Scott (HS)

Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.
Adelaide Medical School, University of Adelaide, 5005 Adelaide, Australia.
Department of Genetics and Molecular Pathology, SA Pathology, 5000 Adelaide, Australia.
ACRF Cancer Genomics Facility, Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.

Natasha L Harvey (NL)

Centre for Cancer Biology, University of South Australia and SA Pathology, 5001 Adelaide, Australia.
Adelaide Medical School, University of Adelaide, 5005 Adelaide, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH